Skip to main content
Equibles
PRVA logo

PRVA · Privia Health Group, Inc. · Earnings Call Transcripts & Audio

Track PRVA — free

Use PRVA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PRVA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$19.69 +0.07 (+0.36%) At close · Sep 30
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$2.52B
Shares
127.73M
Volume · Sep 30 1.34M Avg daily vol (3M) 1.22M

Privia Health Group, Inc. Earnings Call Transcripts

Quarterly earnings calls for Privia Health Group, Inc. (PRVA), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲36.3% $342.90M $1.62M '22 Q3 22-11-10 ▲32.4% $364.42M $17.78M '22 Q4 23-02-28 ▲23.1% $386.28M $7.32M '23 Q1 23-05-04 ▲23.2% $413.35M $7.27M '23 Q2 23-08-03 ▲21.7% $417.28M $5.64M '23 Q3 23-11-03 ▲21% $440.83M $2.84M '23 Q4 24-02-27 ▲7.5% $415.24M $2.98M '24 Q1 24-05-09 ▲2.2% $422.33M $3.47M '24 Q2 24-08-08 ▲4.9% $437.92M $3.54M '24 Q3 24-11-07 ▲4.6% $460.90M $4.40M '24 Q4 25-02-27 ▲15.6% $480.10M $4.22M '25 Q1 25-05-08 ▲23.4% $521.15M $2.69M '25 Q2 25-08-07 ▲32.5% $580.42M $6.86M '25 Q3 25-11-06 ▲17.4% $541.17M $9.15M '25 Q4 26-02-26 ▲25.8% $603.85M $3.06M '26 Q1 26-05-07 LATEST ▲21.4% $632.63M $9.05M '26 Q2 26-08-06
Earnings call
FY26 · Q2
2026-08-06
Privia Health Group, Inc. (PRVA) Q2 2026 Earnings Call Transcript
Confident tone Financial Performance and Guidance Raise Value-Based Care and ACOs CMS Medicare Shared Savings Program Changes
Revenue
$632.63M
▲ 21.4% YoY
Diluted EPS
$0.07
▲ 250% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-07
Privia Health Group, Inc. (PRVA) Q1 2026 Earnings Call Transcript
Confident tone Medical Cost Trend and Risk Appetite 2026 Guidance and Outlook Value-Based Care Platform and Contracts
Revenue
$603.85M
▲ 25.8% YoY
Diluted EPS
$0.02
▼ 33.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-26
Privia Health Group, Inc. (PRVA) Q4 2025 Earnings Call Transcript
Confident tone Financial results and profitability Provider growth and footprint expansion Evolent Health ACO acquisition
Revenue
$541.17M*
▲ 17.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Privia Health Group, Inc. (PRVA) Q3 2025 Earnings Call Transcript
Confident tone MSSP / ACO performance Provider and attribution growth Financial results and margin expansion
Revenue
$580.42M
▲ 32.5% YoY
Diluted EPS
$0.05
▲ 66.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
Privia Health Group, Inc. (PRVA) Q2 2025 Earnings Call Transcript
Confident tone Value-based care diversification MSSP and CMS policy landscape Raised 2025 guidance outlook
Revenue
$521.15M
▲ 23.4% YoY
Diluted EPS
$0.02
▼ 33.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Privia Health Group, Inc. (PRVA) Q1 2025 Earnings Call Transcript
Confident tone Arizona Market Entry / IMS Acquisition M&A Pipeline & Market Expansion Value-Based Care / Risk Model Philosophy
Revenue
$480.10M
▲ 15.6% YoY
Diluted EPS
$0.03
▲ 50% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-27
Privia Health Group, Inc. (PRVA) Q4 2024 Earnings Call Transcript
Confident tone Financial performance and EBITDA expansion Provider growth and density Free cash flow and balance sheet strength
Revenue
$460.90M*
▲ 4.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Privia Health Group, Inc. (PRVA) Q3 2024 Earnings Call Transcript
Confident tone MSSP / Shared Savings Performance Diversified Business Model 2024 Guidance Outlook
Revenue
$437.92M
▲ 4.9% YoY
Diluted EPS
$0.03
▼ 40% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Privia Health Group, Inc. (PRVA) Q2 2024 Earnings Call Transcript
Confident tone Value-based care and attributed lives Commercial risk and direct-to-employer opportunity Financial performance and 2024 guidance raise
Revenue
$422.33M
▲ 2.2% YoY
Diluted EPS
$0.03
▼ 50% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-09
Privia Health Group, Inc. (PRVA) Q1 2024 Earnings Call Transcript
Positive tone Financial performance and EBITDA MSSP and value-based contracts Medicare Advantage capitation restructuring
Revenue
$415.24M
▲ 7.5% YoY
Diluted EPS
$0.02
▼ 66.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-27
Privia Health Group, Inc. (PRVA) Q4 2023 Earnings Call Transcript
Positive tone 2024 Financial Guidance and Profitability Provider Network Expansion Risk Management in Medicare Advantage
Revenue
$440.83M*
▲ 21% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-03
Privia Health Group, Inc. (PRVA) Q3 2023 Earnings Call Transcript
Revenue
$417.28M
▲ 21.7% YoY
Diluted EPS
$0.05
▲ 400% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-03
Privia Health Group, Inc. (PRVA) Q2 2023 Earnings Call Transcript
Revenue
$413.35M
▲ 23.2% YoY
Diluted EPS
$0.06
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-04
Privia Health Group, Inc. (PRVA) Q1 2023 Earnings Call Transcript
Revenue
$386.28M
▲ 23.1% YoY
Diluted EPS
$0.06
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-28
Privia Health Group, Inc. (PRVA) Q4 2022 Earnings Call Transcript
Revenue
$364.42M*
▲ 32.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-10
Privia Health Group, Inc. (PRVA) Q3 2022 Earnings Call Transcript
Revenue
$342.90M
▲ 36.3% YoY
Diluted EPS
$0.01
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-11
Privia Health Group, Inc. (PRVA) Q2 2022 Earnings Call Transcript
Revenue
$335.54M
▲ 48.6% YoY
Diluted EPS
$-0.10
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-12
Privia Health Group, Inc. (PRVA) Q1 2022 Earnings Call Transcript
Revenue
$313.80M
▲ 46.9% YoY
Diluted EPS
$-0.16
▼ 366.7% YoY
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-22
Privia Health Group, Inc. (PRVA) Q4 2021 Earnings Call Transcript
Revenue
$275.33M*
▲ 28.8% YoY
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-08
Privia Health Group, Inc. (PRVA) Q3 2021 Earnings Call Transcript
Revenue
$251.52M
▲ 21.4% YoY
Diluted EPS
$-0.09
▼ 152.9% YoY
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-09
Privia Health Group, Inc. (PRVA) Q2 2021 Earnings Call Transcript
Revenue
$225.76M
▲ 23.2% YoY
Diluted EPS
$-1.68
▼ 2900% YoY
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-27
Privia Health Group, Inc. (PRVA) Q1 2021 Earnings Call Transcript
Revenue
$213.61M
▲ 0.3% YoY
Diluted EPS
$0.06
▲ 0% YoY
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–22 of 22 earnings calls
Key facts CIK 1759655 CUSIP 74276R102 13F (30d) 13 filings 9 filers Visit website Investor relations